Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:03 AM
Ignite Modification Date:
2025-12-25 @ 1:03 AM
NCT ID:
NCT00724893
Eligibility Criteria:
Inclusion Criteria:
* Treatment-naïve patients with chronic hepatitis C
* Adults (\>18 years of age)
* Prescribed Pegetron Redipen
* Must meet all requirements for treatment with Pegetron Redipen
* Must be able to obtain reimbursement of medication through private or provincial coverage
Exclusion Criteria:
* Active hepatitis B virus (HBV) infection (hepatitis B surface antigen \[HBsAg\] positive)
* HIV antibody positive
* Post liver transplant patients
* Any other exclusion criteria as per the product Monograph
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00724893
Study Brief:
Protocol Section:
NCT00724893